The percentage of CD14+CD16++ non-classical monocytes was decreased in individuals with T2DM with PAD or diabetic individuals without MVD, leading to a skewed ratio of non-classical/intermediate monocyte subsets in favour of CD14++CD16+ intermediate monocytes. This evidence concerns the gene CD14 and type 2 diabetes mellitus.